Your browser doesn't support javascript.
loading
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells.
Peired, Anna Julie; Antonelli, Giulia; Angelotti, Maria Lucia; Allinovi, Marco; Guzzi, Francesco; Sisti, Alessandro; Semeraro, Roberto; Conte, Carolina; Mazzinghi, Benedetta; Nardi, Sara; Melica, Maria Elena; De Chiara, Letizia; Lazzeri, Elena; Lasagni, Laura; Lottini, Tiziano; Landini, Samuela; Giglio, Sabrina; Mari, Andrea; Di Maida, Fabrizio; Antonelli, Alessandro; Porpiglia, Francesco; Schiavina, Riccardo; Ficarra, Vincenzo; Facchiano, Davide; Gacci, Mauro; Serni, Sergio; Carini, Marco; Netto, George J; Roperto, Rosa Maria; Magi, Alberto; Christiansen, Christian Fynbo; Rotondi, Mario; Liapis, Helen; Anders, Hans-Joachim; Minervini, Andrea; Raspollini, Maria Rosaria; Romagnani, Paola.
Afiliação
  • Peired AJ; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Antonelli G; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Angelotti ML; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Allinovi M; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Guzzi F; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Sisti A; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Semeraro R; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Conte C; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Mazzinghi B; Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence 50139, Italy.
  • Nardi S; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Melica ME; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence 50139, Italy.
  • De Chiara L; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Lazzeri E; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Lasagni L; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Lottini T; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence 50139, Italy.
  • Landini S; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence 50139, Italy.
  • Giglio S; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Mari A; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Di Maida F; Nephrology and Dialysis Unit, Meyer Children's University Hospital, Florence 50139, Italy.
  • Antonelli A; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Porpiglia F; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Schiavina R; Excellence Centre for Research, Transfer and High Education for the development of DE NOVO Therapies (DENOTHE), University of Florence, Florence 50139, Italy.
  • Ficarra V; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Facchiano D; Department of Experimental and Clinical Medicine, Section of Internal Medicine, University of Florence, Florence 50139, Italy.
  • Gacci M; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Serni S; Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Florence, Florence 50139, Italy.
  • Carini M; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Netto GJ; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Roperto RM; Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia 25123, Italy.
  • Magi A; Department of Urology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin 10043, Italy.
  • Christiansen CF; Department of Urology, S. Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy.
  • Rotondi M; Department of Urology, University of Padua, Padua 35122, Italy.
  • Liapis H; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Anders HJ; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Minervini A; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Raspollini MR; Department of Urology, Careggi Hospital, University of Florence, Florence 50139, Italy.
  • Romagnani P; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Sci Transl Med ; 12(536)2020 03 25.
Article em En | MEDLINE | ID: mdl-32213630
ABSTRACT
Acute tissue injury causes DNA damage and repair processes involving increased cell mitosis and polyploidization, leading to cell function alterations that may potentially drive cancer development. Here, we show that acute kidney injury (AKI) increased the risk for papillary renal cell carcinoma (pRCC) development and tumor relapse in humans as confirmed by data collected from several single-center and multicentric studies. Lineage tracing of tubular epithelial cells (TECs) after AKI induction and long-term follow-up in mice showed time-dependent onset of clonal papillary tumors in an adenoma-carcinoma sequence. Among AKI-related pathways, NOTCH1 overexpression in human pRCC associated with worse outcome and was specific for type 2 pRCC. Mice overexpressing NOTCH1 in TECs developed papillary adenomas and type 2 pRCCs, and AKI accelerated this process. Lineage tracing in mice identified single renal progenitors as the cell of origin of papillary tumors. Single-cell RNA sequencing showed that human renal progenitor transcriptome showed similarities to PT1, the putative cell of origin of human pRCC. Furthermore, NOTCH1 overexpression in cultured human renal progenitor cells induced tumor-like 3D growth. Thus, AKI can drive tumorigenesis from local tissue progenitor cells. In particular, we find that AKI promotes the development of pRCC from single progenitors through a classical adenoma-carcinoma sequence.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Adenoma / Injúria Renal Aguda / Neoplasias Renais Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Adenoma / Injúria Renal Aguda / Neoplasias Renais Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article